EPIRETINAL MEMBRANES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Effect on Outcomes of Anti-vascular Endothelial Growth Factor Therapy

Retina
Emine Esra KaracaŞengül Özdek

Abstract

To iatients with neovascular age-related macular degenernvestigate the role of epiretinal membrane (ERM) on outcomes of anti-vascular endothelial growth factor therapy in pation (nAMD). This study is a retrospective observational case series and was conducted at the Gazi University School of Medicine, Ankara, Turkey. The reports of the patients with a diagnosis of new-onset nAMD, who were aged at least 50 years and treated with intravitreal anti-vascular endothelial growth factors (ranibizumab or bevacuzimab) between October 2010 and September 2013 in our retina clinic, were reviewed for the vitreomacular interface changes. The study included 90 eyes of 90 patients with nAMD. The mean age of the patients was 70 ± 7.5 years, with 35 (38.9%) being male and 55 (61.1%) being female. According to the examinations with optical coherence tomography and B-mode ultrasonography, 43 patients had "concurrent" vitreomacular adhesion (30 focal, 13 broad; Group 1). Twenty-nine patients had complete posterior vitreous detachment (Group 2) and 18 patients (Group 3) had ERM. The number of injections was highest for the patients with ERM (Group 3), and this difference was statistically significant (P < 0.001). The mean interval between injections...Continue Reading

References

Mar 25, 1992·American Journal of Ophthalmology·H M LambertP F Lopez
May 1, 1993·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·J Sebag
Dec 1, 1996·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·B Weber-Krause, U Eckardt
Jul 22, 1998·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C CapeansM Sánchez-Salorio
Mar 4, 2000·Japanese Journal of Ophthalmology·F OndeşA K Arsan
Apr 14, 2004·Archives of Ophthalmology·Marco A Zarbin
Feb 28, 2006·Survey of Ophthalmology·Larry A DonosoGregory Hageman
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Oct 6, 2006·The New England Journal of Medicine·David M BrownUNKNOWN ANCHOR Study Group
Apr 17, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A LommatzschD Pauleikhoff
Jun 10, 2008·Acta Ophthalmologica·Stephan SchulzePeter Kroll
Dec 9, 2008·American Journal of Ophthalmology·Jimmy K LeeJohn D Gottsch
Jan 23, 2009·American Journal of Ophthalmology·Sung Jun LeeHyoung Jun Koh
Mar 27, 2009·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Carl GlittenbergSusanne Binder
May 16, 2009·The British Journal of Ophthalmology·P MitchellS Wolf
Oct 31, 2009·American Journal of Ophthalmology·Nancy M Holekamp
May 26, 2011·Seminars in Ophthalmology·Amy E Green-Simms, Sophie J Bakri
Oct 17, 2012·Survey of Ophthalmology·Andrew R H SimpsonTimothy L Jackson

❮ Previous
Next ❯

Citations

May 18, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J KwonS H Lim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.